Inhibition of multiplication of Mycobacterium leprae in mouse foot pads by immunization with ribosomal fraction and culture flitrate from Mycobacterium bovis BCG

Vaccine

Volumn 15, Issue 11, 1997, Pages 1214-1217

  Matsuoka, Masanori ^a   Nomaguchi, Hiroko ^a   Yukitake, Hideharu ^b   Ohara, Naoya ^b   Matsumoto, Sohkichi ^b   Mise, Katsutoshi ^c   Yamada, Takeshi ^b  

^a National Institute Leprosy Research   (Japan)

^b NAGASAKI UNIVERSITY   (Japan)

^c NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

Author keywords

BCG culture filtrate; BCG ribosomal vaccine; Leprosy vaccine

Indexed keywords

BCG VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBACTERIAL ACTIVITY; ARTICLE; CONTROLLED STUDY; FOOT PAD; IMMUNIZATION; INFECTION PREVENTION; INTRADERMAL DRUG ADMINISTRATION; LEPROSY; MALE; MOUSE; MYCOBACTERIUM BOVIS; MYCOBACTERIUM LEPRAE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; FILTRATION; FOOT; IMMUNIZATION; MALE; MICE; MICE, INBRED C57BL; MYCOBACTERIUM BOVIS; MYCOBACTERIUM LEPRAE; RIBOSOMAL PROTEINS; RNA, RIBOSOMAL;

EID: 0030819531     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(97)00018-2     Document Type: Article

References (30)

1. Bechelli, L.M., Lwin, K. and Gallego, G.P. et al. BCG vaccination of children against leprosy: nine-year findings of the controlled WHO trial in Burma. Bull. Wld Hlth Organ. 1974, 51, 93-99.
2. Ponnighaus, J.M., Fine, P.E. and Sterne, J.A. et al. Efficacy of BCG vaccine against leprosy and tuberculosis in northern Malawi [see comments]. Lancet 1992, 339, 636-639.
3. Stanley, S.J., Howland, C., Stone, M.M. and Sutherland, I. BCG vaccination of children against leprosy in Uganda: final results. J. Hyg. (London) 1981, 87, 233-248.
4. Convit, J., Sampson, C. and Zuniga, M. et al. Immunoprophylactic trial with combined Mycobacterium leprae / BCG vaccine against leprosy: preliminary results (see comments). Lancet 1992, 339, 446-450.
5. Youmans, A.S. and Youmans, G.P. Immunogenic activity of a ribosomal fraction obtained from Mycobacterium tuberculosis. J. Bacteriol. 1965, 89, 1291-1298.
6. Youmans, G.P. and Youmans, A.S. Factors affecting immunogenic activity of mycobacterial ribosomal and ribonucleic acid preparations. J. Bacteriol. 1969, 99, 42-50.
7. Youmans, A.S. and Youmans, G.P. The effect of metabolic inhibitors and hydroxylamine on the immune response in mice to mycobacterial ribonucleic acid vaccines. J. Immunol. 1974, 112, 271-284.
8. Kawamura, I., Tsukada, H., Yoshikawa, H., Fujita, M., Nomoto, K. and Mitsuyama, M. IFN-γ-producing ability as a possible marker for the protective T cells against Mycobacterium bow's BCG in mice. J. Immunol. 1992, 148, 2887-2893.
9. Orme, I.M. Characteristics and specificity of acquired immunologic memory to Mycobacterium tuberculosis infection. J. Immunol. 1988, 140, 3589-3593.
10. Rook, G.A.W., Steele, J., Barnass, S., Mace, J. and Stanford, J.L. Responsiveness to live M. tuberculosis, and common antigens, of sonicate-stimulated T cell lines from normal donors. Clin. Exp. Immunol. 1986, 63, 105-110.
11. Andersen, P., Askgaard, D., Gottshau, A., Bennedsen, J., Nagai, S. and Heron, I. Identification of immunodominant antigens during infection with Mycobacterium tuberculosis. Scand. J. Immunol. 1992, 36, 823-831.
12. Pal, P.G. and Horwitz, M.A. Immunization with extracellular proteins of Mycobacterium tuberculosis induces cell-mediated immune responses and substantial protective immunity in a guinea pig model of pulmonary tuberculosis. Infect. Immun. 1992, 60, 4781-4792.
13. Shepard, C.C. The experimental disease that follows the injection of human leprosy bacilli into foot-pads of mice. J. Exp. Med. 1960, 112, 445-454.
14. Nagai, S., Matsumoto, J. and Nagasuga, T. Specific skinreactive protein from culture filtrate of Mycobacterium bovis BCG. Infect. Immun. 1981, 31, 1152-1160.
15. Suzuki, Y., Yoshinaga, K., Ono, Y., Nagata, A. and Yamada, T. Organization of rRNA genes in Mycobacterium bovis BCG. J. Bacteriol. 1987, 169, 839-843.
16. Tantimavanich, S., Nagai, S., Nomaguchi, H., Kinomoto, M., Ohara, N. and Yamada, T. Immunological properties of ribosomal proteins from Mycobacterium bovis BCG. Infect. Immun. 1993, 61, 4005-4007.
17. Yamada, T., Nagata, A., Ono, Y., Suzuki, Y. and Yamanouchi, T. Alteration of ribosomes and RNA polymerase in drug-resistant clinical isolates of Mycobacterium tuberculosis. Antimicrobiol. Agents Chemother. 1985, 27, 921-924.
18. Nakamura, M. Elimination of contaminants in a homogenate of nude-mouse footpad experimentally infected with Mycobacterium leprae. Jpn. J. Leprosy 1994, 64, 47-50.
19. Gelber, R.H., Mehra, V. and Bloom, B.R. et al. Vaccination with Mycobacterium leprae proteins inhibits M. leprae multiplication in mouse footpads. Infect. Immun. 1994, 62, 4250-4255.
20. Shepard, C.C. Vaccination of mice against M. leprae infection. Int. J. Leprosy 1976, 44, 222-226.
21. Shepard, C.C. and NcRae, D.H. A method for counting acidfast bacteria. Int. J. Leprosy 1968, 36, 78-82.
22. Wada, N., Ohara, N. and Kameoka, M. et al. Long-lasting immune response induced by recombinant Bacillus Calmette-Guérin (BCG) secretion system. Scand. J. Immunol. 1996, 43, 202-209.
23. Bachrach, G., Banai, M., Bardenstein, S., Hoida, G., Genizi, A. and Bercovier, H. Brucella ribosomal protein L7/L12 is a major component in the antigenicity of brucellin INRA for delayed-type hypersensitivity in brucella-sensitized guinea pigs. Infect. Immun. 1994, 62, 5361-5366.
24. Oliveira, S.C., Zhu, Y. and Splitter, A.G. Recombinant L7/L12 ribosomal protein and γ-irradiated Brucella abortus induce a T-helper 1 subset response from murine CD4+ T cell. Immunology 1994, 83, 659-664.
25. Horwitz, M.A., Lee, B.W., Dillon, B.J. and Harth, G. Protective immunity against tuberculosis induced by vaccination with major extracellular proteins of Mycobacterium tuberculosis. Proc. Natl Acad. Sci. USA 1995, 92, 1530-1534.
26. Daniel, T.M. and Anderson, P.A. The isolation by immunoabsorbent affinity chromatography and physicochemical characterization of Mycobacterium tuberculosis antigen 5. Am. Rev. Respir. Dis. 1978, 117, 533-539.
27. Espitia, C. and Mancilla, R. Identification, isolation and partial characterization of Mycobacterium tuberculosis glycoprotein antigens. Clin. Exp. Immunol. 1989, 77, 378-383.
28. Fifis, T., Costopoulos, C., Radford, A.J., Bacic, A. and Wood, P.R. Purification and characterization of major antigens from a Mycobacterium bovis culture filtrate. Infect. Immun. 1991, 59, 800-807.
29. Yano, O., Fukuda, T., Abe, H. and Sudo, T. Purification and characterization of a tuberculin-active substance from Mycobacterium bovis BCG. J. Biochem. (Tokyo) 1984, 96, 523-531.
30. Yadava, A. and Mukherjee, R. An immunodominant 30-kDa antigen of a candidate anti-leprosy vaccine, Mycobactertium w, shares T and B cell determinants with M. leprae and M. tuberculosis. Med. Microbiol. Immunol. 1993, 182, 243-253.